CAR T Cells: Second-Line Treatment Option for NHL? - NCI
By A Mystery Man Writer
Description
Recent trial results suggest that CAR T cells may be superior to standard treatments for B-cell NHL that has not responded or has returned after treatment.
Prospects in the management of patients with follicular lymphoma beyond first-line therapy
Engineering CAR T-Cell Therapy to Overcome Limitations - NCI
CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
Evidence of CD-19 CAR T cell therapy in multiple myeloma. Before (a)
Non-Hodgkin's Chemotherapy, Radiation, & Immunotherapy Treatments
Cancers, Free Full-Text
A Review of CAR T-Cell Therapies Approved for the Treatment of Relapsed and Refractory B-Cell Lymphomas
CAR T-Cell therapy for the management of mantle cell lymphoma, Molecular Cancer
Understanding Non-Hodgkin Lymphoma and CAR T-Cell Therapy - Penn Medicine Lancaster General Health
CAR T Cells: Second-Line Treatment Option for NHL? - NCI
Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy - Biology of Blood and Marrow Transplantation
JPM, Free Full-Text
Tumor buster - where will the CAR-T cell therapy 'missile' go?, Molecular Cancer
from
per adult (price varies by group size)